An overview of the 6th World Symposium on Pulmonary Hypertension von Galiè, Nazzareno, McLaughlin, Vallerie V, Rubin, Lewis J, Simonneau, Gerald

Volltext

Selexipag for the Treatment of Pulmonary Arterial Hypertension von Sitbon, Olivier, Channick, Richard, Chin, Kelly M, Frey, Aline, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, Lang, Irene M, Preiss, Ralph, Rubin, Lewis J, Di Scala, Lilla, Tapson, Victor, Adzerikho, Igor, Liu, Jinming, Moiseeva, Olga, Zeng, Xiaofeng, Simonneau, Gérald, McLaughlin, Vallerie V

Volltext

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension von Galiè, Nazzareno, Barberà, Joan A, Frost, Adaani E, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, McLaughlin, Vallerie V, Peacock, Andrew J, Simonneau, Gérald, Vachiery, Jean-Luc, Grünig, Ekkehard, Oudiz, Ronald J, Vonk-Noordegraaf, Anton, White, R. James, Blair, Christiana, Gillies, Hunter, Miller, Karen L, Harris, Julia H.N, Langley, Jonathan, Rubin, Lewis J

Volltext

Risk stratification and medical therapy of pulmonary arterial hypertension von Galiè, Nazzareno, Channick, Richard N, Frantz, Robert P, Grünig, Ekkehard, Jing, Zhi Cheng, Moiseeva, Olga, Preston, Ioana R, Pulido, Tomas, Safdar, Zeenat, Tamura, Yuichi, McLaughlin, Vallerie V

Volltext

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension von Hoeper, Marius M., Badesch, David B., Ghofrani, H. Ardeschir, Gibbs, J. Simon R., Gomberg-Maitland, Mardi, McLaughlin, Vallerie V., Preston, Ioana R., Souza, Rogerio, Waxman, Aaron B., Grünig, Ekkehard, Kopeć, Grzegorz, Meyer, Gisela, Olsson, Karen M., Rosenkranz, Stephan, Xu, Yayun, Miller, Barry, Fowler, Marcie, Butler, John, Koglin, Joerg, de Oliveira Pena, Janethe, Humbert, Marc

Volltext

Management of Pulmonary Arterial Hypertension von McLaughlin, Vallerie V., MD, Shah, Sanjiv J., MD, Souza, Rogerio, MD, Humbert, Marc, MD, PhD

Volltext

Endothelin receptor blockers in cardiovascular disease von RICH, Stuart, MCLAUGHLIN, Vallerie V

Volltext

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study von Coghlan, J Gerry, Denton, Christopher P, Grünig, Ekkehard, Bonderman, Diana, Distler, Oliver, Khanna, Dinesh, Müller-Ladner, Ulf, Pope, Janet E, Vonk, Madelon C, Doelberg, Martin, Chadha-Boreham, Harbajan, Heinzl, Harald, Rosenberg, Daniel M, McLaughlin, Vallerie V, Seibold, James R

Volltext

Looking to the future: a new decade of pulmonary arterial hypertension therapy von McLaughlin, V V

Volltext

Survival with first-line bosentan in patients with primary pulmonary hypertension von McLaughlin, V. V, Sitbon, O, Badesch, D. B, Barst, R. J, Black, C, Galie, N, Rainisio, M, Simonneau, G, Rubin, L. J

Volltext

Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension von Khanna, Dinesh, Gladue, Heather, Channick, Richard, Chung, Lorinda, Distler, Oliver, Furst, Daniel E., Hachulla, Eric, Humbert, Marc, Langleben, David, Mathai, Stephen C., Saggar, Rajeev, Visovatti, Scott, Altorok, Nezam, Townsend, Whitney, FitzGerald, John, McLaughlin, Vallerie V.

Volltext

Updated Treatment Algorithm of Pulmonary Arterial Hypertension von Galiè, Nazzareno, MD, Corris, Paul A., MD, Frost, Adaani, MD, Girgis, Reda E., MD, Granton, John, MD, Jing, Zhi Cheng, MD, Klepetko, Walter, MD, McGoon, Michael D., MD, McLaughlin, Vallerie V., MD, Preston, Ioana R., MD, Rubin, Lewis J., MD, Sandoval, Julio, MD, Seeger, Werner, MD, Keogh, Anne, MD

Volltext

Survival in primary pulmonary hypertension: The impact of epoprostenol therapy von MCLAUGHLIN, Vallerie V, SHILLINGTON, Alicia, RICH, Stuart

Volltext

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality von McLaughlin, Vallerie V., Hoeper, Marius M., Channick, Richard N., Chin, Kelly M., Delcroix, Marion, Gaine, Sean, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Lang, Irene M., Mehta, Sanjay, Pulido, Tomás, Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam, Tapson, Victor F., Perchenet, Loïc, Preiss, Ralph, Verweij, Pierre, Rubin, Lewis J., Galiè, Nazzareno

Volltext

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intra... von Sitbon, O, McLaughlin, V V, Badesch, D B, Barst, R J, Black, C, Galiè, N, Humbert, M, Rainisio, M, Rubin, L J, Simonneau, G

Volltext

Treatment Goals of Pulmonary Hypertension von McLaughlin, Vallerie V., MD, Gaine, Sean Patrick, MD, PhD, Howard, Luke S., DPhil, Leuchte, Hanno H., MD, Mathier, Michael A., MD, Mehta, Sanjay, MD, Palazzini, Massimillano, MD, Park, Myung H., MD, Tapson, Victor F., MD, Sitbon, Olivier, MD, PhD

Volltext

Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension: The SUPER-2 Study von RUBIN, Lewis J, BADESCH, David B, BARST, Robyn J, FLEMING, Thomas R, GALIE, Nazzareno, SIMONNEAU, Gerald, GHOFRANI, Hossein A, OAKES, Michael, LAYTON, Gary, SERDAREVIC-PEHAR, Marjana, MCLAUGHLIN, Uallerie V

Volltext

Survival in patients with pulmonary arterial hypertension treated with first-line bosentan von McLaughlin, V. V.

Volltext

Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study von Benza, Raymond L., Chin, Kelly M., Gaine, Sean, Galiè, Nazzareno, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Sitbon, Olivier, Doad, Gurinderpal, Yen, Joseph, Tang, Xiaoqin, Tapson, Victor

Volltext

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension : Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Mult... von GALIE, Nazzareno, OLSCHEWSKI, Horst, GERBER, Michael J, DUFTON, Christopher, WIENS, Brian L, RUBIN, Lewis J, OUDIZ, Ronald J, TORRES, Fernando, FROST, Adaani, GHOFRANI, Hossein A, BADESCH, David B, MCGOON, Michael D, MCLAUGHLIN, Vallerie V, ROECKER, Ellen B

Volltext